These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


267 related items for PubMed ID: 611013

  • 21. Drug-induced movement disorders in institutionalised adults with mental retardation: clinical characteristics and risk factors.
    Sachdev P.
    Aust N Z J Psychiatry; 1992 Jun; 26(2):242-8. PubMed ID: 1353672
    [Abstract] [Full Text] [Related]

  • 22. Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia.
    Pourcher E, Cohen H, Cohen D, Baruch P, Bouchard RH.
    Brain Cogn; 1993 Sep; 23(1):81-7. PubMed ID: 8105825
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
    Dufresne RL, Wagner RL.
    J Clin Psychiatry; 1988 Nov; 49(11):435-8. PubMed ID: 2903141
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Depot neuroleptics: side effects and safety.
    Marder SR.
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
    [Abstract] [Full Text] [Related]

  • 28. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
    Barnes TR.
    Psychiatr Dev; 1987 Feb; 5(4):301-19. PubMed ID: 2895467
    [Abstract] [Full Text] [Related]

  • 29. Exacerbation of tardive dyskinesia by Joseph disease.
    Browne JL, Hart RR.
    J Clin Psychiatry; 1986 Jun; 47(6):315-6. PubMed ID: 3711030
    [Abstract] [Full Text] [Related]

  • 30. [Tardive dyskinesia. A possible complication of chronic treatment with neuroleptics].
    D'Aquila F, Rampello L.
    Riv Neurol; 1990 Jun; 60(4):140-5. PubMed ID: 1982720
    [Abstract] [Full Text] [Related]

  • 31. Neuroleptic drugs: how to reduce the risk of tardive dyskinesia.
    DeVeaugh-Geiss J.
    Geriatrics; 1979 Jul; 34(7):59-61, 66. PubMed ID: 36330
    [Abstract] [Full Text] [Related]

  • 32. Affective disorders and tardive dyskinesia.
    Casey DE.
    Encephale; 1988 Sep; 14 Spec No():221-6. PubMed ID: 2905650
    [Abstract] [Full Text] [Related]

  • 33. Tardive dyskinesia and depressive illness.
    Davis KL, Berger PA, Hollister LE.
    Psychopharmacol Commun; 1976 Sep; 2(2):125-30. PubMed ID: 10603
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Does clozapine cause tardive dyskinesia?
    Kane JM, Woerner MG, Pollack S, Safferman AZ, Lieberman JA.
    J Clin Psychiatry; 1993 Sep; 54(9):327-30. PubMed ID: 8104929
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Tardive dyskinesia and diabetes mellitus.
    Ganzini L, Casey DE, Hoffman WF, Heintz RT.
    Psychopharmacol Bull; 1992 Sep; 28(3):281-6. PubMed ID: 1362276
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Tardive dyskinesia: prevalence, incidence, and risk factors.
    Kane JM, Woerner M, Lieberman J.
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):52S-56S. PubMed ID: 3065365
    [Abstract] [Full Text] [Related]

  • 40. [Neuroleptic tardive dyskinesias. Completion of the inquiry regarding 1,480 psychiatric hospital patients].
    Bourgeois M, Boueilh P, Peyre C, Gauthier-Bernard F.
    Ann Med Psychol (Paris); 1977 Apr; 1(4):660-79. PubMed ID: 603190
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.